Clinical Trial Update: Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating semaglutide for weight management in adults with obesity or overweight has completed, with results posted on 2024-11-29.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 3 | Status: COMPLETED | Results posted: 2024-11-29